1832 Asset Management’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-157
| Closed | -$21K | – | 889 |
|
|
2021
Q2 | $21K | Sell |
157
-3,255
| -95% | -$435K | ﹤0.01% | 663 |
|
|
2021
Q1 | $446K | Sell |
3,412
-105
| -3% | -$13.7K | ﹤0.01% | 486 |
|
|
2020
Q4 | $508K | Sell |
3,517
-661
| -16% | -$95.5K | ﹤0.01% | 534 |
|
|
2020
Q3 | $470K | Buy |
4,178
+1,535
| +58% | +$173K | ﹤0.01% | 511 |
|
|
2020
Q2 | $294K | Buy |
+2,643
| New | +$294K | ﹤0.01% | 515 |
|
|
2020
Q1 | – | Sell |
-5,211
| Closed | -$497K | – | 770 |
|
|
2019
Q4 | $497K | Buy |
5,211
+4,148
| +390% | +$396K | ﹤0.01% | 472 |
|
|
2019
Q3 | $81K | Hold |
1,063
| – | – | ﹤0.01% | 551 |
|
|
2019
Q2 | $93K | Hold |
1,063
| – | – | ﹤0.01% | 560 |
|
|
2019
Q1 | $93K | Hold |
1,063
| – | – | ﹤0.01% | 489 |
|
|
2018
Q4 | $77K | Hold |
1,063
| – | – | ﹤0.01% | 473 |
|
|
2018
Q3 | $102K | Sell |
1,063
-17,746
| -94% | -$1.7M | ﹤0.01% | 525 |
|
|
2018
Q2 | $1.8M | Sell |
18,809
-1,039
| -5% | -$99.2K | 0.01% | 386 |
|
|
2018
Q1 | $1.75M | Sell |
19,848
-1,568
| -7% | -$138K | 0.01% | 378 |
|
|
2017
Q4 | $1.81M | Buy |
21,416
+6,160
| +40% | +$521K | 0.01% | 379 |
|
|
2017
Q3 | $1.28M | Hold |
15,256
| – | – | ﹤0.01% | 406 |
|
|
2017
Q2 | $1.18M | Sell |
15,256
-39,489
| -72% | -$3.05M | 0.01% | 422 |
|
|
2017
Q1 | $3.8M | Buy |
+54,745
| New | +$3.8M | 0.01% | 355 |
|